Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines
J Yang, K Li, D He, J Gu, J Xu, J Xie… - Drug Metabolism …, 2020 - Taylor & Francis
Today, it is very challenging to develop new active pharmaceutical ingredients. Developing
good preparations of well-recognized natural medicines is certainly a practical and …
good preparations of well-recognized natural medicines is certainly a practical and …
Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines
S Yan, Y Liu, J Feng, H Zhao, Z Yu, J Zhao… - Drug Metabolism …, 2018 - Taylor & Francis
Drug metabolism plays vital roles in the absorption and pharmacological activity of poorly
soluble natural medicines. It is important to choose suitable delivery systems to increase the …
soluble natural medicines. It is important to choose suitable delivery systems to increase the …
Metabolic pathways and pharmacokinetics of natural medicines with low permeability
M Zeng, L Yang, D He, Y Li, M Shi… - Drug metabolism …, 2017 - Taylor & Francis
Drug metabolism plays an important role in the drug disposal process. Differences in
pharmacokinetics among individuals are the basis for personalized medicine. Natural …
pharmacokinetics among individuals are the basis for personalized medicine. Natural …
Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement
D Patil, S Pattewar, S Palival, G Patil… - Journal of Drug Delivery …, 2019 - jddtonline.info
Lipid based drug delivery system such as Solid lipid nanoparticle (SLN) and Nanostructured
lipid carriers (NLC) are among the most promising drug delivery system used in many …
lipid carriers (NLC) are among the most promising drug delivery system used in many …
Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism
Z Zhang, F Gao, S Jiang, L Ma, Y Li - Current Drug Metabolism, 2012 - ingentaconnect.com
Oral administration remains the most preferred route for the treatment of many diseases due
to its convenience and adaptability. However, the presystemic metabolism may be an …
to its convenience and adaptability. However, the presystemic metabolism may be an …
[HTML][HTML] Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
Nowadays exploration of novel lipid-based formulations is akin to a magnet for researchers
worldwide for improving the in vivo performance of highly lipophilic drugs. Over the last few …
worldwide for improving the in vivo performance of highly lipophilic drugs. Over the last few …
Nanostructured lipid carriers for improved delivery of therapeutics via the oral route
Drug delivery via the oral route has always been challenging for poorly soluble drugs. Acid‐
induced hydrolysis, enzymatic degradation, and poor mucosal absorbency remain the …
induced hydrolysis, enzymatic degradation, and poor mucosal absorbency remain the …
[HTML][HTML] Novel nano-drug delivery system for natural products and their application
L Huang, XH Huang, X Yang, JQ Hu, YZ Zhu… - Pharmacological …, 2024 - Elsevier
The development of natural products for potential new drugs faces obstacles such as
unknown mechanisms, poor solubility, and limited bioavailability, which limit the broadened …
unknown mechanisms, poor solubility, and limited bioavailability, which limit the broadened …
[HTML][HTML] Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration
Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …
Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations
S Beg, S Swain, M Rizwan, M Irfanuddin… - Current Drug …, 2011 - ingentaconnect.com
Poor solubility remains a major challenge for pharmaceutical industry, which is now
considered to be an area of prime importance in the field of biomedical research …
considered to be an area of prime importance in the field of biomedical research …